About – Equinox Clinical Trial
Equinox Clinical Trial Services brings together two senior consultants with extensive experience
At Equinox Clinical Trial Services, two senior consultants combine their extensive expertise in regulatory affairs, clinical development, and pharmaceutical product registration. Our blend of regulator insight and industry experience delivers strategic, reliable solutions for both innovators and generics.
Dr James Swales
Former medical assessor at the UK Medicines and Healthcare products Regulatory Agency (MHRA). Dr Swales has held clinical development, regulatory and medical affairs roles across the industry, including at Novartis and Johnson & Johnson. His expertise spans regulatory strategy, dossier authoring, clinical development planning, study design, and OTC reclassification.
Dr Muhaned Al-Hindawi
Former senior pharmaceutical assessor at the UK Medicines and Healthcare products Regulatory Agency (MHRA). Specialist in CMC and regulatory submissions, with particular focus on CTD Module 3 dossiers, biowaivers and bioequivalence studies. Dr Al-Hindawi has supported companies globally across lifecycle maintenance, variations, and marketing authorisations in the UK, EU, and MENA regions.